当前位置：
X-MOL 学术
›
Circulation
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2.
Circulation ( IF 37.8 ) Pub Date : 2023-01-17 , DOI: 10.1161/circulationaha.122.061688 Sha Chen 1 , Qian Wang 1 , Andriana Christodoulou 2 , Nikolaos Mylonas 2 , Diane Bakker 1 , Rianne Nederlof 3 , Markus W Hollmann 1 , Nina C Weber 1 , Ruben Coronel 4 , Vincent Wakker 5 , Vincent M Christoffels 5 , Ioanna Andreadou 2 , Coert J Zuurbier 1
中文翻译：
Sodium Glucose Cotransporter-2 抑制剂 Empagliflozin 可独立于 Sodium Glucose Cotransporter-2 减少梗塞面积。
更新日期：2023-01-17
Circulation ( IF 37.8 ) Pub Date : 2023-01-17 , DOI: 10.1161/circulationaha.122.061688 Sha Chen 1 , Qian Wang 1 , Andriana Christodoulou 2 , Nikolaos Mylonas 2 , Diane Bakker 1 , Rianne Nederlof 3 , Markus W Hollmann 1 , Nina C Weber 1 , Ruben Coronel 4 , Vincent Wakker 5 , Vincent M Christoffels 5 , Ioanna Andreadou 2 , Coert J Zuurbier 1
Affiliation
中文翻译：
Sodium Glucose Cotransporter-2 抑制剂 Empagliflozin 可独立于 Sodium Glucose Cotransporter-2 减少梗塞面积。
京公网安备 11010802027423号